INTEGRATED CORE STRATEGIES (US) LLC - 14 Oct 2025 SCHEDULE 13G/A Report for Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS)

Filing Manager
INTEGRATED CORE STRATEGIES (US) LLC
Reporting Manager
Millennium Management LLC
Security
Astria Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
ATXS
Disclosed Ownership
222,101 shares
Ownership
0.4%
Form type
SCHEDULE 13G/A
Filing time
20 Oct 2025, 16:23:01 UTC
Date of event
14 Oct 2025
Previous filing
18 Jun 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"INTEGRATED CORE STRATEGIES (US) LLC disclosed 0.4% ownership in Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS) on 14 Oct 2025."

Quick Takeaways

  • INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G/A for Astria Therapeutics, Inc. Common Stock, par value $0.001 per share (ATXS).
  • Disclosed ownership: 0.4%.
  • Date of event: 14 Oct 2025.

What Changed

  • Previous schedule filing date: 18 Jun 2025.
  • Current filing was accepted on 20 Oct 2025, 16:23.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 0.3% 163,238 0 163,238 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 0.4% 222,101 0 222,101 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 0.4% 222,101 0 222,101 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 0.4% 222,101 0 222,101 /s/ Israel A. Englander Israel A. Englander

Sponsored